Medical Properties Trust - MPW Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $18.30
  • Forecasted Upside: 54.30 %
  • Number of Analysts: 10
  • Breakdown:
  • 0 Sell Ratings
  • 6 Hold Ratings
  • 3 Buy Ratings
  • 1 Strong Buy Ratings
$11.86
▲ +0.42 (3.67%)

This chart shows the closing price for MPW by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Medical Properties Trust Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MPW and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MPW

Analyst Price Target is $18.30
▲ +54.30% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for Medical Properties Trust in the last 3 months. The average price target is $18.30, with a high forecast of $23.00 and a low forecast of $15.00. The average price target represents a 54.30% upside from the last price of $11.86.

This chart shows the closing price for MPW for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 10 contributing investment analysts is to buy stock in Medical Properties Trust. This rating has held steady since July 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/10/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
7/9/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/7/2021
  • 1 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/5/2022
  • 1 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
4/5/2022
  • 1 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 0 sell ratings
7/4/2022
  • 1 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 0 sell ratings
9/2/2022
  • 1 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 0 sell ratings
10/2/2022

Latest Recommendations

  • 1 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/22/2022Raymond JamesLower TargetStrong-Buy$20.00 ➝ $18.00Low
9/16/2022Deutsche Bank AktiengesellschaftLower TargetHold$17.00 ➝ $15.00Low
8/4/2022BarclaysLower TargetOverweight$27.00 ➝ $23.00N/A
7/29/2022MizuhoLower TargetBuy$26.00 ➝ $20.00Low
7/14/2022Credit Suisse GroupDowngradeOutperform ➝ Neutral$23.00 ➝ $17.00Low
7/13/2022Deutsche Bank AktiengesellschaftLower TargetHold$20.00 ➝ $17.00Low
7/11/2022Truist FinancialLower Target$23.00 ➝ $18.00N/A
7/7/2022KeyCorpLower TargetOverweight$23.00 ➝ $18.00N/A
6/30/2022Jefferies Financial GroupLower TargetHold$19.00 ➝ $15.00Low
6/22/2022JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$24.00 ➝ $18.00Low
4/27/2022Deutsche Bank AktiengesellschaftLower Target$25.00 ➝ $20.00High
4/22/2022Jefferies Financial GroupDowngradeBuy ➝ Hold$25.00 ➝ $20.00High
3/24/2022Truist FinancialLower TargetHold$26.00 ➝ $23.00Low
3/11/2022Bank of AmericaDowngradeBuy ➝ Neutral$21.00Medium
2/14/2022Credit Suisse GroupLower TargetOutperform$27.00 ➝ $26.00High
2/1/2022Credit Suisse GroupInitiated CoverageOutperformLow
1/20/2022MizuhoBoost Target$23.00 ➝ $26.00High
1/3/2022Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$27.00 ➝ $25.00Low
10/29/2021Raymond JamesBoost TargetStrong-Buy$25.00 ➝ $26.00Medium
10/27/2021Bank of AmericaUpgradeNeutral ➝ Buy$21.50 ➝ $24.00High
10/25/2021Raymond JamesInitiated CoverageStrong-Buy$25.00Medium
8/11/2021Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$23.00Low
7/14/2021MizuhoReiterated RatingBuy$23.00Low
7/6/2021Bank of AmericaDowngradeBuy ➝ Neutral$21.50Low
6/14/2021Wolfe ResearchInitiated CoveragePeer Perform$23.00High
6/3/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$25.00 ➝ $27.00Medium
5/10/2021Royal Bank of CanadaReiterated RatingOutperform ➝ Sector Perform$24.00 ➝ $23.00Low
5/3/2021Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$24.00 ➝ $23.00Medium
2/8/2021BarclaysBoost TargetOverweight$23.00 ➝ $25.00Medium
1/22/2021Truist FinancialDowngradeBuy ➝ Hold$21.00 ➝ $22.00Low
1/21/2021KeyCorpBoost TargetOverweight$22.00 ➝ $24.00Medium
12/15/2020Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$24.00Medium
11/27/2020Truist FinancialBoost Target$20.00 ➝ $21.00Low
9/9/2020Colliers SecuritiesInitiated CoverageBuy$23.00Low
9/1/2020Stifel NicolausReiterated RatingBuy$21.00Low
8/24/2020MizuhoUpgradeNeutral ➝ Buy$20.00 ➝ $23.00Low
7/10/2020Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$23.00 ➝ $19.00Medium
6/25/2020SunTrust BanksBoost TargetBuy$19.00 ➝ $20.00Medium
4/23/2020SunTrust BanksLower TargetBuy$22.00 ➝ $19.00Low
4/21/2020KeyCorpLower TargetOverweight$25.00 ➝ $20.00High
4/3/2020Wells Fargo & CompanyLower TargetEqual Weight$21.00 ➝ $16.00Low
4/3/2020JPMorgan Chase & Co.Lower TargetOverweight$25.00 ➝ $20.00High
3/30/2020MizuhoDowngradeBuy ➝ Neutral$27.00 ➝ $19.00Low
3/23/2020Bank of AmericaUpgradeNeutral ➝ BuyHigh
3/18/2020BarclaysReiterated RatingBuy$22.00Medium
3/9/2020Royal Bank of CanadaReiterated RatingBuy$25.00Medium
1/16/2020KeyCorpBoost TargetOverweight$22.00 ➝ $23.00Medium
1/14/2020Robert W. BairdBoost TargetNeutral$20.00 ➝ $22.00Low
12/26/2019MizuhoBoost TargetBuy$25.00 ➝ $26.00Low
12/19/2019MizuhoInitiated CoverageBuy$25.00Medium
10/21/2019BarclaysSet TargetBuy$22.00Low
10/14/2019Bank of AmericaInitiated CoverageNeutral$19.50Low
9/12/2019Berenberg BankInitiated CoverageBuy$22.00Low
9/4/2019JPMorgan Chase & Co.Set TargetBuy$21.00Low
9/3/2019BarclaysInitiated CoverageOverweight$20.00High
8/27/2019SunTrust BanksBoost TargetBuy$20.00 ➝ $21.00High
8/12/2019Stifel NicolausSet TargetBuy$21.00Low
7/29/2019Deutsche Bank AktiengesellschaftUpgradeHold ➝ BuyLow
7/23/2019Stifel NicolausUpgradeHold ➝ Buy$18.00 ➝ $19.00High
7/2/2019SunTrust BanksUpgradeHold ➝ Buy$19.00 ➝ $20.00High
3/29/2019Deutsche Bank AktiengesellschaftBoost TargetHold ➝ Hold$14.00 ➝ $16.00High
2/13/2019Jefferies Financial GroupUpgradeHold ➝ Buy$18.00 ➝ $23.00Medium
2/11/2019Mitsubishi UFJ Financial GroupBoost TargetNeutral$17.00Low
12/19/2018JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightLow
12/18/2018SunTrust BanksDowngradeBuy ➝ HoldMedium
12/11/2018Wells Fargo & CompanyUpgradeUnderperform ➝ Market Perform$13.50 ➝ $17.50Low
11/2/2018Mitsubishi UFJ Financial GroupBoost TargetNeutral$15.00Low
11/1/2018Stifel NicolausSet TargetHold$14.00Medium
10/1/2018JMP SecuritiesSet TargetBuy$16.00High
7/17/2018Jefferies Financial GroupDowngradeBuy ➝ Hold$15.00Medium
5/31/2018Wells Fargo & CompanyBoost TargetUnderperform ➝ Underperform$11.50 ➝ $13.00Low
3/19/2018Deutsche Bank AktiengesellschaftLower TargetHold ➝ Hold$13.50 ➝ $13.00High
1/10/2018Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$14.00 ➝ $13.50Low
1/5/2018Robert W. BairdDowngradeOutperform ➝ Neutral$15.00 ➝ $13.00Medium
12/15/2017JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$14.50High
11/3/2017SunTrust BanksReiterated RatingBuy$15.00N/A
(Data available from 10/2/2017 forward)

News Sentiment Rating

1.09 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 7 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/6/2022
  • 10 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/5/2022
  • 17 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/5/2022
  • 6 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/4/2022
  • 7 very positive mentions
  • 2 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
7/4/2022
  • 12 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/3/2022
  • 12 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/2/2022
  • 14 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/2/2022

Current Sentiment

  • 14 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Medical Properties Trust logo
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospitals with 431 facilities and roughly 43,000 licensed beds in nine countries and across four continents on a pro forma basis. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Read More

Today's Range

Now: $11.86
Low: $11.53
High: $12.14

50 Day Range

MA: $14.93
Low: $11.44
High: $17.24

52 Week Range

Now: $11.86
Low: $11.35
High: $24.13

Volume

24,995,272 shs

Average Volume

12,412,898 shs

Market Capitalization

$7.10 billion

P/E Ratio

5.93

Dividend Yield

10.14%

Beta

0.8

Frequently Asked Questions

What sell-side analysts currently cover shares of Medical Properties Trust?

The following equities research analysts have issued reports on Medical Properties Trust in the last twelve months: Bank of America Co., Barclays PLC, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., JPMorgan Chase & Co., KeyCorp, Mizuho, Raymond James, StockNews.com, TheStreet, and Truist Financial Co..
View the latest analyst ratings for MPW.

What is the current price target for Medical Properties Trust?

10 Wall Street analysts have set twelve-month price targets for Medical Properties Trust in the last year. Their average twelve-month price target is $18.30, suggesting a possible upside of 54.3%. Barclays PLC has the highest price target set, predicting MPW will reach $23.00 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of $15.00 for Medical Properties Trust in the next year.
View the latest price targets for MPW.

What is the current consensus analyst rating for Medical Properties Trust?

Medical Properties Trust currently has 6 hold ratings, 3 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MPW will outperform the market and that investors should add to their positions of Medical Properties Trust.
View the latest ratings for MPW.

What other companies compete with Medical Properties Trust?

How do I contact Medical Properties Trust's investor relations team?

Medical Properties Trust's physical mailing address is 1000 URBAN CENTER DRIVE SUITE 501, BIRMINGHAM AL, 35242. The real estate investment trust's listed phone number is (205) 969-3755 and its investor relations email address is [email protected] The official website for Medical Properties Trust is www.medicalpropertiestrust.com. Learn More about contacing Medical Properties Trust investor relations.